Search Results - "Limegrover, Colleen"
-
1
Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology
Published in Nature neuroscience (01-11-2021)“…Amyotrophic lateral sclerosis overlapping with frontotemporal dementia (ALS/FTD) is a fatal and currently untreatable disease characterized by rapid cognitive…”
Get full text
Journal Article -
2
Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
Published in Journal of neuroscience research (01-04-2021)“…α‐Synuclein oligomers are thought to have a pivotal role in sporadic and familial Parkinson's disease (PD) and related α‐synucleinopathies, causing…”
Get full text
Journal Article -
3
Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
Published in Journal of neurochemistry (01-05-2021)“…Several mutations conferring protection against Alzheimer's disease (AD) have been described, none as profound as the A673T mutation, where carriers are four…”
Get full text
Journal Article -
4
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
Published in Alzheimer's & dementia (01-08-2021)“…Introduction Amyloid beta (Aβ) oligomers are one of the most toxic structural forms of the Aβ protein and are hypothesized to cause synaptotoxicity and memory…”
Get full text
Journal Article -
5
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma‑2 Receptor Complex for Alzheimer’s Disease
Published in ACS medicinal chemistry letters (09-09-2021)“…An unbiased phenotypic neuronal assay was developed to measure the synaptotoxic effects of soluble Aβ oligomers. A collection of CNS druglike small molecules…”
Get full text
Journal Article -
6
Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
Published in Journal of neuroscience methods (01-07-2021)“…Mature primary neuronal cultures are an important model of the nervous system, but limited scalability has been a major challenge in their use for drug…”
Get full text
Journal Article